Please ensure Javascript is enabled for purposes of website accessibility

Why Chemours Stock Jumped 13% Today

By Reuben Gregg Brewer – May 6, 2020 at 11:53AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Chemical company Chemours rose swiftly at the open as investors digested its earnings news.

What happened

Shares of specialty chemical company Chemours (CC -5.33%) jumped nearly 14% as trading opened for the day. Although they quickly settled down to a mid-single-digit gain by 10 a.m. EDT, the quick jump was clearly a reaction to the company's earnings, which were released after the close yesterday.   

So what

Chemours' top line fell slightly, going from $1.4 billion in the first quarter of 2019 to $1.3 billion in the same period of 2020. Although the company's titanium coatings business did well (sales were up 10% in the segment), its other two divisions (fluoroproducts and chemical solutions) saw year-over-year sales declines. One key factor in the quarter was pricing, which was weak across all of the business. Adjusted earnings per share, meanwhile, was up 13% year over year despite the headwinds. Margins improved across the company. All in, it was a solid quarter and investors reacted in an upbeat manner.   

A person in a white lab coat working with chemicals.

Image source: Getty Images.

However, Chemours was sure to point out that it had started to feel the impact of COVID-19-related economic shutdowns as the first quarter drew to a close. It noted, not unreasonably, that the economic hit from the global effort to slow the spread of the coronavirus has clouded the future. Management has, thus, pulled its full-year guidance. It has also started a cost-cutting program and trimmed its capital budget by a fairly substantial 30%. Chemours appears to be battening down the hatches as it prepares for a storm.   

Now what

Although the first quarter obviously pleased investors, the bigger picture is that demand for Chemours chemical products was already starting to weaken in the first quarter. That situation is likely to get worse in the second quarter, and perhaps for longer, as the world deals with the coronavirus. It appears that management is hinting strongly that 2020 could be a tough year from here on out. Long-term investors should pay attention. 

Reuben Gregg Brewer has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Chemours Company Stock Quote
The Chemours Company
$25.23 (-5.33%) $-1.42

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.